Peter Kaiser
Chief Development Officer at Ocular Therapeutix, Inc (OCUL) since October 2024
Peter Kaiser has filed 13 insider reports with the SEC since October 2024, as chief Development Officer at Ocular Therapeutix, Inc (OCUL). In the last 12 months Peter Kaiser sold $116K of stock on the open market. In the latest filing, on August 26, 2026, Peter Kaiser sold 3,035 shares of Ocular Therapeutix, Inc (OCUL) for $32.7K at an average of $10.77.
- Filings
- 13
- Companies
- 1
- Bought on market
- None
- Sold on market
- $327K
Companies where Peter Kaiser is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Development Officersince October 2024 | 264,378 | $327K | $5.57 | Aug 26, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 24, 2026-$32.7KOCULChief Development Officer Kaiser Peter sold $32,687 worth of shares (3,035 units at $10.77), decreasing direct ownership by 1% to 264,378 units to cover withholding taxForm 4Open-market sale
- May 26, 2026-$24.3KOCULChief Development Officer Kaiser Peter sold $24,329 worth of shares (2,967 units at $8.20), decreasing direct ownership by 1% to 266,141 units to satisfy withholding obligationForm 4Open-market sale
- Feb 23, 2026-$23.3KOCULChief Development Officer Kaiser Peter sold $23,267 worth of shares (2,810 units at $8.28), decreasing direct ownership by 1% to 269,108 unitsForm 4Open-market sale
- Jan 2, 2026OCULChief Development Officer Kaiser Peter was granted 79,112 shares, increasing direct ownership by 41% to 271,918 unitsForm 4Grant or award
- Nov 24, 2025-$36.1KOCULChief Development Officer Kaiser Peter sold $36,144 worth of shares (3,007 units at $12.02), decreasing direct ownership by 2% to 191,433 unitsForm 4Open-market sale
- Nov 24, 2025~$36.2KOCULPeter Kaiser plans to sell 3,007 shares (~$36.2K)Form 144Planned sale
- Oct 2, 2025-$106KOCULChief Development Officer Kaiser Peter sold $106,473 worth of shares (9,653 units at $11.03), decreasing direct ownership by 5% to 194,440 unitsForm 4Open-market sale
- Aug 25, 2025-$36.3KOCULChief Development Officer Kaiser Peter sold $36,252 worth of shares (3,011 units at $12.04), decreasing direct ownership by 1% to 204,093 unitsForm 4Open-market sale
- May 23, 2025-$21.3KOCULChief Development Officer Kaiser Peter sold $21,324 worth of shares (2,974 units at $7.17), decreasing direct ownership by 1% to 207,104 unitsForm 4Open-market sale
- Feb 24, 2025-$20.7KOCULChief Development Officer Kaiser Peter sold $20,672 worth of shares (3,009 units at $6.87), decreasing direct ownership by 1% to 210,078 unitsForm 4Open-market sale
- Nov 25, 2024-$26.1KOCULChief Development Officer Kaiser Peter sold $26,102 worth of shares (2,897 units at $9.01), decreasing direct ownership by 1% to 213,087 unitsForm 4Open-market sale
- Oct 2, 2024OCULChief Development Officer Kaiser Peter was granted 100,000 shares, increasing direct ownership by 86% to 215,984 unitsForm 4Grant or award
- Oct 2, 2024OCULNew insider Kaiser Peter claimed ownership of 115,984 sharesForm 3New insider
Compare Peter Kaiser with
- Peter Kaiser vs Riad Sherif1 shared
- Peter Kaiser vs Namrata Saroj1 shared
- Peter Kaiser vs Donald Notman1 shared
- Peter Kaiser vs Jeffrey S. Heier1 shared
- Peter Kaiser vs Sanjay Nayak1 shared
- Peter Kaiser vs Pravin Dugel1 shared
Other insiders at the same companies
- Riad SherifOCUL
- Namrata SarojOCUL
- Donald NotmanOCUL
- Sanjay NayakOCUL
- Jeffrey S. HeierOCUL
- Pravin DugelOCUL
- Charles M WardenOCUL
- Adrienne L GravesOCUL
- Jason Shand RobinsOCUL
- Seung Suh HongOCUL
- Lindstrom Richard L MdOCUL
- Merilee RainesOCUL
- Leslie J. WilliamsOCUL
- Nadia WaheedOCUL
- David Wayne RobinsonOCUL
- Todd AndermanOCUL
Questions about Peter Kaiser
- What is Peter Kaiser's role at Ocular Therapeutix, Inc?
- Peter Kaiser reports to the SEC as chief Development Officer at Ocular Therapeutix, Inc (OCUL), according to the latest filing on August 26, 2026.
- How many shares does Peter Kaiser own?
- After the latest filing that states it, Peter Kaiser directly owned 264,378 shares of Ocular Therapeutix, Inc (OCUL). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter Kaiser bought or sold stock recently?
- The most recent open-market sale was on August 24, 2026: sold 3,035 shares of Ocular Therapeutix, Inc (OCUL) for $32.7K at an average of $10.77.
- How do I get alerts when Peter Kaiser files?
- Follow Peter Kaiser on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Peter Kaiser filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Peter Kaiser (SEC CIK 0002011869). Totals count each trade once, skipping amendments whose original is on file, from Oct 4, 2024 on. View on SEC EDGAR · Get this as JSON